Among the investigated thiosemicarbazide derivatives, compound 3 had the highest ability to induce caspase-8 activation in MCF-7 cells, while triple-negative MDA-MB-231 breast cancer cells were more sensitive to thiosemicarbazide derivative 2. The gene discussed is CASP8; the disease is breast carcinoma.